David Lange
About David Lange
David Lange is the Associate Director of QA IT and eSystems at Bristol Myers Squibb, specializing in Cell Therapy Development and Operations. He has over 30 years of experience in the pharmaceutical and biotechnology sectors, with a focus on quality and compliance.
Current Position at Bristol Myers Squibb
David Lange serves as the Associate Director, QA IT and eSystems, Cell Therapy Development and Operations (CTDO) at Bristol Myers Squibb. He has held this position since January 1, 2021. In this role, Lange is involved in overseeing quality assurance related to IT and electronic systems within the company's cell therapy development operations.
Previous Roles at Bristol Myers Squibb and Celgene
Before his current position, David Lange held various roles within Bristol Myers Squibb and Celgene Corporation. He was Manager, IT QA/eSystems | Quality Engineering at CTDO for nine months in 2020. Prior to that, he had a four-year tenure as Manager, IT Q&C from 2016 to 2020 at BMS (formerly Celgene Corporation). His other roles at Celgene include Senior Analyst IT Quality Operations from 2013 to 2016, Information Technology Global Delivery Systems from 2011 to 2013, Senior Manager, Global Operations Lead, CSM from 2009 to 2011, Medical Affairs Information Systems from 2006 to 2009, and Senior Manager, Medical Development from 2004 to 2006.
Early Career at Janssen and Education
David Lange's early career includes a position at Janssen as SP/BRM from 2001 to 2004. He holds a Master's Degree in Information Systems from Stevens Institute of Technology, which he earned from 2002 to 2004. Before that, he completed a BA in Biopsychology with a minor in Mathematics at Skidmore College in May 1983. Lange completed his high school education at Metuchen High School from 1976 to 1979.
Experience in Pharmaceutical and Biotechnology Sectors
With over 30 years of experience in the pharmaceutical and biotechnology sectors of healthcare, David Lange has a comprehensive background in quality and compliance across various domains. These include clinical, medical affairs, research, early drug development, and pharmacovigilance. Additionally, he has over 15 years of experience in clinical research and development across all phases and in information technology.